Tingting Zhang-Kharas has responsibility for all aspects of the JLABS in US Northeast (including NYC, Boston, and Philadelphia), as well as supporting the broader ecosystem through external presence and partnerships. She is responsible for sourcing and leading diligence for JLABS applicants and prospective companies in alignment with J&J focus areas to ensure strategic fit. She collaborates with the broader JJI team to enable partnerships between J&J and JLABS companies to strengthen the innovation pipeline.

Tingting joined the JLABS team from IPSEN, where she led the Oncology External Innovation team as a Senior Director, to identify and explore global business development opportunities in the oncology field. Prior to IPSEN, Tingting held key roles in the Oncology Search and Evaluation team at Loxo Oncology at Eli Lilly, where she spearheaded the evaluation of a variety of oncology companies and assets for partnering and venture capital investment considerations, and managed academic research collaborations, leading to multiple in-licensing, out-licensing, and acquisition deals. In her earlier career, Tingting had extensive experience in biopharma consulting at Navigant as a Senior Consultant and in technology transfer and business development at Memorial Sloan Kettering Cancer Center as a Licensing Manager.

With an exceptional track record throughout her past roles, Tingting is passionate about identifying and supporting innovations in the life science industry, particularly within the NYC region.  She received her Ph.D. in Immunology from Harvard University and Bachelor of Medical Sciences from Peking University Health Science Center.